(“Lilly”) will acquire Organovo’s FXR program, including its lead asset, FXR314. “This is a significant milestone for our efforts to advance medicines for IBD using insights from our ...
After hours: March 20 at 7:48:50 PM EDT Loading Chart for ONVO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback